Citi analyst Hidemaru Yamaguchi downgraded SanBio to Neutral from Buy with a price target of 500 yen, down from 1,800 yen. The analyst thinks resolving the SB623 manufacturing issue will take time.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>